Newly released documents show profit-seeking behind price hikes at Turing, Valeant

WASHINGTON/NEW YORK (Reuters) - A decision by Turing Pharmaceuticals to raise the price of a lifesaving drug by 5,000 percent drove up some patient co-pays to as high as $16,000, according to excerpts of documents that congressional committee members released on Tuesday.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro